Does HUMAN IMMUNOGLOBULIN G Cause Inappropriate schedule of product administration? 1,879 Reports in FDA Database

Q: Does HUMAN IMMUNOGLOBULIN G cause Inappropriate schedule of product administration?

1,879 reports of Inappropriate schedule of product administration have been filed with the FDA for HUMAN IMMUNOGLOBULIN G, representing 2.7% of all HUMAN IMMUNOGLOBULIN G adverse event reports.

Q: How dangerous is Inappropriate schedule of product administration from HUMAN IMMUNOGLOBULIN G?

Of 1,879 reports, 96 (5.1%) resulted in death and 840 required hospitalization.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 1,879 reports of Inappropriate schedule of product administration have been filed in association with HUMAN IMMUNOGLOBULIN G (BIVIGAM). This represents 2.7% of all adverse event reports for HUMAN IMMUNOGLOBULIN G.

1,879

Reports of Inappropriate schedule of product administration with HUMAN IMMUNOGLOBULIN G

2.7%

of all HUMAN IMMUNOGLOBULIN G reports

Deaths

840

Hospitalizations

How Dangerous Is Inappropriate schedule of product administration From HUMAN IMMUNOGLOBULIN G?

Of the 1,879 reports, 96 (5.1%) resulted in death, 840 (44.7%) required hospitalization, and 10 (0.5%) were considered life-threatening.

Is Inappropriate schedule of product administration Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for HUMAN IMMUNOGLOBULIN G. However, 1,879 reports have been filed with the FAERS database.

What Other Side Effects Does HUMAN IMMUNOGLOBULIN G Cause?

Headache (7,885) Off label use (5,872) Fatigue (5,423) Nausea (4,454) Sinusitis (4,409) Pyrexia (4,076) Drug ineffective (3,923) Pruritus (3,775) Dyspnoea (3,518) Malaise (3,180)

What Other Drugs Cause Inappropriate schedule of product administration?

ADAPALENE (16,473) DUPILUMAB (14,927) AVOBENZONE\OCTISALATE\OCTOCRYLENE (12,546) INSULIN GLARGINE (8,982) INFLIXIMAB (6,847) INFLIXIMAB-DYYB (5,977) SECUKINUMAB (4,817) DULAGLUTIDE (3,606) VEDOLIZUMAB (3,259) SACUBITRIL\VALSARTAN (2,870)

Which HUMAN IMMUNOGLOBULIN G Alternatives Have Lower Inappropriate schedule of product administration Risk?

HUMAN IMMUNOGLOBULIN G vs HUMAN IMMUNOGLOBULIN G\HYALURONIDASE HUMAN IMMUNOGLOBULIN G vs HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN HUMAN IMMUNOGLOBULIN G vs HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE, RECOMBINANT HUMAN IMMUNOGLOBULIN G vs HUMAN RABIES VIRUS IMMUNE GLOBULIN HUMAN IMMUNOGLOBULIN G vs HUMAN RHO IMMUNE GLOBULIN

HUMAN IMMUNOGLOBULIN G Full Profile All Inappropriate schedule of product administration Reports All Drugs Causing Inappropriate schedule of product administration HUMAN IMMUNOGLOBULIN G Demographics